Advertisement
Screener

Citadel Advisors LLC Historic Quarter Change: USA Bonds: Convertible Notes, New, 2020 Q3, Page 2

CITADEL ADVISORS LLC historic quarter change: USA Bonds: Convertible Notes, New

In convertible notes that pay a coupon (listed in the US), over 51 quarters from 2013-06-30 to 2026-03-31, CITADEL ADVISORS LLC opened 1,005 positions, added to 266, reduced 334 and sold out of 965.

  • Q3 2020: Stock OMEROS CORP; Country of operation —; Class NOTE 6.250%11/1; Principal before $0.
  • Q3 2020: Stock TPG SPECIALTY LENDING INC; Country of operation —; Class NOTE 4.500% 8/0; Principal before $0.
  • Q3 2020: Stock COWEN INC; Country of operation —; Class NOTE 3.000%12/1; Principal before $0.
  • Q3 2020: Stock ENCORE CAP EUROPE FIN LTD; Country of operation —; Class NOTE 4.500% 9/0; Principal before $0.

Each consecutive pair of Form 13F-HR filings compared (SEC CIK 1423053), 51 quarters: Q1 2026 (2025-12-31 to 2026-03-31, filed 2026-05-15); Q4 2025 (2025-09-30 to 2025-12-31, filed 2026-02-17); Q3 2025 (2025-06-30 to 2025-09-30, filed 2025-11-14); Q2 2025 (2025-03-31 to 2025-06-30, filed 2025-08-14); Q1 2025 (2024-12-31 to 2025-03-31, filed 2025-05-15); Q4 2024 (2024-09-30 to 2024-12-31, filed 2025-02-14); Q3 2024 (2024-06-30 to 2024-09-30, filed 2024-11-14); Q2 2024 (2024-03-31 to 2024-06-30, filed 2024-08-14); Q1 2024 (2023-12-31 to 2024-03-31, filed 2024-05-15); Q4 2023 (2023-09-30 to 2023-12-31, filed 2024-02-14); Q3 2023 (2023-06-30 to 2023-09-30, filed 2023-11-14); Q2 2023 (2023-03-31 to 2023-06-30, filed 2023-08-14); Q1 2023 (2022-12-31 to 2023-03-31, filed 2023-05-15); Q4 2022 (2022-09-30 to 2022-12-31, filed 2023-02-14); Q3 2022 (2022-06-30 to 2022-09-30, filed 2022-11-14); Q2 2022 (2022-03-31 to 2022-06-30, filed 2022-08-15); Q1 2022 (2021-12-31 to 2022-03-31, filed 2022-05-16); Q4 2021 (2021-09-30 to 2021-12-31, filed 2022-02-14); Q3 2021 (2021-06-30 to 2021-09-30, filed 2021-11-15); Q2 2021 (2021-03-31 to 2021-06-30, filed 2021-08-16); Q1 2021 (2020-12-31 to 2021-03-31, filed 2021-05-17); Q4 2020 (2020-09-30 to 2020-12-31, filed 2021-02-16); Q3 2020 (2020-06-30 to 2020-09-30, filed 2020-11-16); Q2 2020 (2020-03-31 to 2020-06-30, filed 2020-08-14); Q1 2020 (2019-12-31 to 2020-03-31, filed 2020-05-15); Q4 2019 (2019-09-30 to 2019-12-31, filed 2020-02-14); Q3 2019 (2019-06-30 to 2019-09-30, filed 2019-11-14); Q2 2019 (2019-03-31 to 2019-06-30, filed 2019-08-14); Q1 2019 (2018-12-31 to 2019-03-31, filed 2019-05-15); Q4 2018 (2018-09-30 to 2018-12-31, filed 2019-02-14); Q3 2018 (2018-06-30 to 2018-09-30, filed 2018-11-13); Q2 2018 (2018-03-31 to 2018-06-30, filed 2018-08-10); Q1 2018 (2017-12-31 to 2018-03-31, filed 2018-05-11); Q4 2017 (2017-09-30 to 2017-12-31, filed 2018-02-09); Q3 2017 (2017-06-30 to 2017-09-30, filed 2017-11-09); Q2 2017 (2017-03-31 to 2017-06-30, filed 2017-08-11); Q1 2017 (2016-12-31 to 2017-03-31, filed 2017-05-12); Q4 2016 (2016-09-30 to 2016-12-31, filed 2017-02-10); Q3 2016 (2016-06-30 to 2016-09-30, filed 2016-11-10); Q2 2016 (2016-03-31 to 2016-06-30, filed 2016-08-12); Q1 2016 (2015-12-31 to 2016-03-31, filed 2016-05-13); Q4 2015 (2015-09-30 to 2015-12-31, filed 2016-02-12); Q3 2015 (2015-06-30 to 2015-09-30, filed 2015-11-16); Q2 2015 (2015-03-31 to 2015-06-30, filed 2015-08-14); Q1 2015 (2014-12-31 to 2015-03-31, filed 2015-05-15); Q4 2014 (2014-09-30 to 2014-12-31, filed 2015-02-18); Q3 2014 (2014-06-30 to 2014-09-30, filed 2014-11-14); Q2 2014 (2014-03-31 to 2014-06-30, filed 2014-08-14); Q1 2014 (2013-12-31 to 2014-03-31, filed 2014-05-15); Q4 2013 (2013-09-30 to 2013-12-31, filed 2014-02-14); Q3 2013 (2013-06-30 to 2013-09-30, filed 2013-11-14). Rows for the same security, class and put/call are added together. Value change is the filed value at each quarter end, so it includes the price move. Only the filings held here are compared; the firm's 13F-HR filings go back to the quarter ended 2009-12-31.

QuarterStockCountry of operationClassPrincipal beforePrincipal afterShare changeValue beforeValue afterValue changeFiled
Q3 2020OMEROS CORP
CUSIP 682143AE2
—NOTE 6.250%11/1$0$17,730,000+17,730,000$0$16,836+$16,8362020-11-16
Q3 2020TPG SPECIALTY LENDING INC
CUSIP 87265KAD4
—NOTE 4.500% 8/0$0$16,300,000+16,300,000$0$16,773+$16,7732020-11-16
Q3 2020COWEN INC
CUSIP 223622AE1
—NOTE 3.000%12/1$0$15,181,000+15,181,000$0$16,548+$16,5482020-11-16
Q3 2020ENCORE CAP EUROPE FIN LTD
CUSIP 29260UAA5
—NOTE 4.500% 9/0$0$15,000,000+15,000,000$0$16,406+$16,4062020-11-16
Q3 2020MAGNACHIP SEMICONDUCTOR SA
CUSIP 55932XAB0
—NOTE 5.000% 3/0$0$9,530,000+9,530,000$0$16,082+$16,0822020-11-16
Q3 2020TIMKENSTEEL CORP
CUSIP 887399AA1
—NOTE 6.000% 6/0$0$18,500,000+18,500,000$0$15,925+$15,9252020-11-16
Q3 2020ALTERYX INC
CUSIP 02156BAB9
—NOTE 0.500% 6/0$0$6,052,000+6,052,000$0$15,895+$15,8952020-11-16
Q3 2020INNOVIVA INC
CUSIP 45781MAB7
—NOTE 2.500% 8/1$0$16,219,000+16,219,000$0$15,802+$15,8022020-11-16
Q3 2020RETROPHIN INC
CUSIP 761299AB2
—NOTE 2.500% 9/1$0$18,500,000+18,500,000$0$15,793+$15,7932020-11-16
Q3 2020INPHI CORP
CUSIP 45772FAC1
—NOTE 0.750% 9/0$0$7,588,000+7,588,000$0$15,231+$15,2312020-11-16
Q3 2020LIVE NATION ENTERTAINMENT IN
CUSIP 538034AQ2
—NOTE 2.500% 3/1$0$12,539,000+12,539,000$0$13,959+$13,9592020-11-16
Q3 2020INCYTE CORP
CUSIP 45337CAN2
—NOTE 1.250%11/1$0$7,716,000+7,716,000$0$13,393+$13,3932020-11-16
Q3 2020CHIMERA INVT CORP
CUSIP 16934QAA7
—NOTE 7.000% 4/0$0$10,000,000+10,000,000$0$12,617+$12,6172020-11-16
Q3 2020GSV CAP CORP
CUSIP 36191JAC5
—NOTE 4.750% 3/2$0$11,000,000+11,000,000$0$12,540+$12,5402020-11-16
Q3 2020CALAMP CORP
CUSIP 128126AD1
—NOTE 2.000% 8/0$0$15,000,000+15,000,000$0$12,304+$12,3042020-11-16
Q3 2020VISHAY INTERTECHNOLOGY INC
CUSIP 928298AP3
—NOTE 2.250% 6/1$0$12,000,000+12,000,000$0$11,640+$11,6402020-11-16
Q3 2020VIAVI SOLUTIONS INC
CUSIP 925550AE5
—NOTE 1.750% 6/0$0$10,029,000+10,029,000$0$11,155+$11,1552020-11-16
Q3 2020SEACOR HOLDINGS INC
CUSIP 811904AN1
—NOTE 3.250% 5/1$0$14,642,000+14,642,000$0$11,114+$11,1142020-11-16
Q3 2020HELIX ENERGY SOLUTIONS GRP I
CUSIP 42330PAK3
—NOTE 6.750% 2/1$0$13,500,000+13,500,000$0$10,951+$10,9512020-11-16
Q3 2020HERITAGE INS HLDGS INC
CUSIP 42727JAB8
—NOTE 5.875% 8/0$0$10,663,000+10,663,000$0$10,728+$10,7282020-11-16
Q3 2020TILRAY INC
CUSIP 88688TAB6
—NOTE 5.000%10/0$0$24,990,000+24,990,000$0$10,320+$10,3202020-11-16
Q3 2020THERAVANCE INC
CUSIP 88338TAB0
—NOTE 2.125% 1/1$0$10,750,000+10,750,000$0$10,301+$10,3012020-11-16
Q3 2020BLACKLINE INC
CUSIP 09239BAB5
—NOTE 0.125% 8/0$0$7,000,000+7,000,000$0$9,644+$9,6442020-11-16
Q3 2020VEONEER INC
CUSIP 92336XAA7
—NOTE 4.000% 6/0$0$9,500,000+9,500,000$0$9,341+$9,3412020-11-16
Q3 2020IQIYI INC
CUSIP 46267XAB4
—NOTE 3.750%12/0$0$8,000,000+8,000,000$0$8,520+$8,5202020-11-16
Q3 2020CSG SYS INTL INC
CUSIP 126349AF6
—NOTE 4.250% 3/1$0$7,926,000+7,926,000$0$8,240+$8,2402020-11-16
Q3 2020KAMAN CORP
CUSIP 483548AF0
—NOTE 3.250% 5/0$0$6,600,000+6,600,000$0$6,517+$6,5172020-11-16
Q3 2020PACIRA BIOSCIENCES
CUSIP 695127AD2
—NOTE 2.375% 4/0$0$5,572,000+5,572,000$0$6,389+$6,3892020-11-16
Q3 2020SEACOR HOLDINGS INC
CUSIP 811904AM3
—NOTE 2.500%12/1$0$7,110,000+7,110,000$0$6,312+$6,3122020-11-16
Q3 2020MOMO INC
CUSIP 60879BAB3
—NOTE 1.250% 7/0$0$8,000,000+8,000,000$0$6,281+$6,2812020-11-16
Q3 2020XERIS PHARMACEUTICALS INC
CUSIP 98422LAA5
—NOTE 5.000% 7/1$0$3,000,000+3,000,000$0$5,846+$5,8462020-11-16
Q3 2020OPKO HEALTH INC
CUSIP 68375NAD5
—NOTE 4.500% 2/1$0$4,550,000+4,550,000$0$5,396+$5,3962020-11-16
Q3 2020APELLIS PHARMACEUTICALS INC
CUSIP 03753UAB2
—NOTE 3.500% 9/1$0$4,500,000+4,500,000$0$4,865+$4,8652020-11-16
Q3 2020ZENDESK INC
CUSIP 98936JAB7
—NOTE 0.250% 3/1$0$2,109,000+2,109,000$0$3,616+$3,6162020-11-16
Q3 2020PTC THERAPEUTICS INC
CUSIP 69366JAB7
—NOTE 3.000% 8/1$0$3,000,000+3,000,000$0$3,409+$3,4092020-11-16
Q3 2020MERITOR INC
CUSIP 59001KAC4
—NOTE 7.875% 3/0$0$1,784,000+1,784,000$0$3,145+$3,1452020-11-16
Q3 2020NEVRO CORP
CUSIP 64157FAA1
—NOTE 1.750% 6/0$0$1,810,000+1,810,000$0$2,715+$2,7152020-11-16
Q3 2020ALTAIR ENGR INC
CUSIP 021369AA1
—NOTE 0.250% 6/0$0$2,000,000+2,000,000$0$2,220+$2,2202020-11-16
Q3 2020JAZZ INVESTMENTS I LTD
CUSIP 472145AD3
—NOTE 1.500% 8/1$0$2,000,000+2,000,000$0$2,029+$2,0292020-11-16
Q3 2020ALTERYX INC
CUSIP 02156BAD5
—NOTE 0.500% 8/0$0$2,000,000+2,000,000$0$2,003+$2,0032020-11-16